CLINICIAN-LED ORAL WEIGHT LOSS
A weight loss plan built around you - not just a pill.
Talo pairs the new Wegovy® GLP-1 pill with 1:1 UK clinician-led coaching*. Join the waiting list to hear when we launch.
- UK-registered clinicians overseeing your care
- 1:1 nutrition and exercise coaching
- GLP-1 treatment tailored to you
- UK-registered clinicians overseeing your care
- 1:1 nutrition and exercise coaching
- GLP-1 treatment tailored to you
About the Wegovy® pillA once-daily pill.
A once-daily pill.
No needles.
Wegovy® pill is the first peptide-based GLP-1 oral treatment for weight management. It contains semaglutide - the same active ingredient trusted by millions worldwide - now in a tablet designed to fit into everyday life.
- Mean weight loss*
- ~14–17%
- Dose
- 1 / day
over 64 weeks in the OASIS 4 trial
once-daily oral tablet
- Helps regulate appetite and calorie intake
- Helps you feel fuller, less hungry, and more in control of cravings
- For adults with a BMI ≥30, or ≥27 with a weight-related condition
*Alongside a reduced-calorie diet and increased physical activity. Wegovy® is a prescription-only medicine. Suitability is decided by a clinician.
Be first when we open the doors.
Waiting list members get priority access, launch pricing, and a one-to-one intake call with a Talo clinician.